Fig. 3

U2OS cells treated with IC50 concentration of the peptide showed reduced migration. U2OS cells were grown until sufficiently confluent and vertical scratches were administered and subsequently treated with IC50 of the peptide. A Wound closure percentage (%) of cells treated for 24 h. Closure decreased significantly, by approximately 20%, between peptide treated and untreated U2OS cells (*** P < 0.001, n = 6). B Wound closure representative images from untreated and treated U2OS cells with IC50 peptide for 24 h